Amylyx Pharmaceuticals' (AMLX) Relyvrio Receives Approval from FDA
Go back to Amylyx Pharmaceuticals' (AMLX) Relyvrio Receives Approval from FDA| (NASDAQ: AMLX) | Delayed: 33.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.94 | 52 Week High | $ | |||
| Open | $33.94 | 52 Week Low | $ | |||
| Day High | $33.94 | P/E | N/A | |||
| Day Low | $33.94 | EPS | $ | |||
| Volume | 3,049 | |||||
